ACE2 and COVID-19: We reported an increase in patients with severe COVID-19 (1332.21 ± 535.05 pg/mL, p < 0.001), as the highest levels of serum ACE2 were observed in vaccinated patients (2240.79 ± 882.53 pg/mL, p < 0.001) (Figure 1A).